UBS AM’s KORU Medical Systems KRMD Stock Holding History

UBS AM’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239	Hold	57	–	–	﹤0.01%	3691
2026 Q1	$246	Buy	+57	New	+$283	﹤0.01%	3773

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simcoe Capital Spokane, Washington $164M AUM

MIM

Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return

LCM

Lionhunter Capital Management New York $222M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

UBS AM's KRMD Position: Q2 2026 in Review

UBS AM held its KORU Medical Systems (KRMD) position steady in Q2 2026 at 57 shares worth $239. The position accounts for ﹤0.01% of the portfolio, ranked #3691.

UBS AM first reported a position in KRMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $246 in Q1 2026. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

UBS AM held 57 shares of KORU Medical Systems worth $239 as of Q2 2026.
UBS AM left its KORU Medical Systems share count unchanged in Q2 2026.
KORU Medical Systems made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3691 holding.
UBS AM first reported a position in KORU Medical Systems in Q1 2026 and has held it in 2 quarters since.
UBS AM's KORU Medical Systems position peaked at $246 in Q1 2026.
85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.